Rana BS, Thomas MR, Calvert PA, Monaghan MJ, Hildick-Smith D. Echocardiographic evaluation of patent foramen ovale prior to device closure. JACC Cardiovasc Imaging. 2010;3(7):749–60.
Article
PubMed
Google Scholar
Cho KK, Khanna S, Lo P, Cheng D, Roy D. Persistent pathology of the patent foramen ovale: a review of the literature. Med J Aust. 2021;215(2):89–93.
Article
PubMed
Google Scholar
Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318(18):1148–52.
Article
CAS
PubMed
Google Scholar
Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991–9.
Article
CAS
PubMed
Google Scholar
Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092–100.
Article
CAS
PubMed
Google Scholar
Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083–91.
Article
CAS
PubMed
Google Scholar
Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011–21.
Article
CAS
PubMed
Google Scholar
Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022–32.
Article
PubMed
Google Scholar
Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033–42.
Article
PubMed
Google Scholar
Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol. 2018;71(20):2335–42.
Article
PubMed
Google Scholar
Smer A, Salih M, Mahfood Haddad T, Guddeti R, Saadi A, Saurav A, et al. Meta-analysis of randomized controlled trials on patent foramen ovale closure versus medical therapy for secondary prevention of cryptogenic stroke. Am J Cardiol. 2018;121(11):1393–9.
Article
PubMed
Google Scholar
Tsivgoulis G, Katsanos AH, Mavridis D, Frogoudaki A, Vrettou AR, Ikonomidis I, et al. Percutaneous patent foramen ovale closure for secondary stroke prevention: network meta-analysis. Neurology. 2018;91(1):e8–18.
Article
PubMed
Google Scholar
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association/american stroke association. Stroke. 2021;52(7):e364–467.
Article
PubMed
Google Scholar
Elgendy AY, Saver JL, Amin Z, Boudoulas KD, Carroll JD, Elgendy IY, et al. Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurol. 2020;77(7):878–86.
Article
PubMed
Google Scholar
Kent DM, Saver JL, Kasner SE, Nelson J, Carroll JD, Chatellier G, et al. Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke. JAMA. 2021;326(22):2277–86.
Article
PubMed
PubMed Central
Google Scholar
Ntaios G, Weng SF, Perlepe K, Akyea R, Condon L, Lambrou D, et al. Data-driven machine-learning analysis of potential embolic sources in embolic stroke of undetermined source. Eur J Neurol. 2021;28(1):192–201.
Article
CAS
PubMed
Google Scholar
Guan W, Ko D, Khurshid S, Trisini Lipsanopoulos AT, Ashburner JM, Harrington LX, et al. Automated electronic phenotyping of cardioembolic stroke. Stroke. 2021;52(1):181–9.
Article
CAS
PubMed
Google Scholar
Ralambondrainy H. A conceptual version of the K-means algorithm. Pattern Recogn Lett. 1995;16(11):1147–57.
Article
Google Scholar
Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81(7):619–25.
Article
PubMed
PubMed Central
Google Scholar
Mojadidi MK, Zaman MO, Elgendy IY, Mahmoud AN, Patel NK, Agarwal N, et al. Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol. 2018;71(9):1035–43.
Article
PubMed
Google Scholar
Zonneveld TP, Richard E, Vergouwen MD, Nederkoorn PJ, de Haan R, Roos YB, et al. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2018;7(7):Cd007858.
PubMed
Google Scholar
Redfern J, McKevitt C, Dundas R, Rudd AG, Wolfe CD. Behavioral risk factor prevalence and lifestyle change after stroke: a prospective study. Stroke. 2000;31(8):1877–81.
Article
CAS
PubMed
Google Scholar
Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, et al. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex septal closure system in patients with a stroke and/or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale) trial. JACC Cardiovasc Interv. 2014;7(8):913–20.
Article
PubMed
Google Scholar
Zhou J, Chou OHI, Wong KHG, Lee S, Leung KSK, Liu T, et al. Development of an electronic frailty index for predicting mortality and complications analysis in pulmonary hypertension using random survival forest model. Front Cardiovasc Med. 2022;9:735906.
Article
PubMed
PubMed Central
Google Scholar